Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

Chantal Reusken, Matthias Niedrig, Suzan Pas, Pedro Anda, Sylvain Baize, Remi Charrel, Antonino Di Caro, Christian Drosten, Maria Dolores Fernandez-Garcia, Leticia Franco, Stephan Gunther, Isabelle Leparc-Goffart, Byron Martina, Delphine Pannetier, Anna Papa, Maria Paz Sanchez-Seco, Olli Vapalahti, Marion Koopmans

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease (EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made.

Original languageEnglish
Pages (from-to)124-134
Number of pages11
JournalJournal of Clinical Virology
Volume62
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Ebolavirus
Ebola Hemorrhagic Fever
Democratic Republic of the Congo
Western Africa
Virus Diseases
Disease Outbreaks
Rare Diseases
Emergencies
Public Health
Equipment and Supplies

Keywords

  • Diagnostics
  • Ebola virus
  • Laboratory preparedness
  • Viral haemorrhagic fever

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases
  • Medicine(all)

Cite this

Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. / Reusken, Chantal; Niedrig, Matthias; Pas, Suzan; Anda, Pedro; Baize, Sylvain; Charrel, Remi; Di Caro, Antonino; Drosten, Christian; Fernandez-Garcia, Maria Dolores; Franco, Leticia; Gunther, Stephan; Leparc-Goffart, Isabelle; Martina, Byron; Pannetier, Delphine; Papa, Anna; Sanchez-Seco, Maria Paz; Vapalahti, Olli; Koopmans, Marion.

In: Journal of Clinical Virology, Vol. 62, 01.01.2015, p. 124-134.

Research output: Contribution to journalArticle

Reusken, C, Niedrig, M, Pas, S, Anda, P, Baize, S, Charrel, R, Di Caro, A, Drosten, C, Fernandez-Garcia, MD, Franco, L, Gunther, S, Leparc-Goffart, I, Martina, B, Pannetier, D, Papa, A, Sanchez-Seco, MP, Vapalahti, O & Koopmans, M 2015, 'Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014', Journal of Clinical Virology, vol. 62, pp. 124-134. https://doi.org/10.1016/j.jcv.2014.11.007
Reusken, Chantal ; Niedrig, Matthias ; Pas, Suzan ; Anda, Pedro ; Baize, Sylvain ; Charrel, Remi ; Di Caro, Antonino ; Drosten, Christian ; Fernandez-Garcia, Maria Dolores ; Franco, Leticia ; Gunther, Stephan ; Leparc-Goffart, Isabelle ; Martina, Byron ; Pannetier, Delphine ; Papa, Anna ; Sanchez-Seco, Maria Paz ; Vapalahti, Olli ; Koopmans, Marion. / Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014. In: Journal of Clinical Virology. 2015 ; Vol. 62. pp. 124-134.
@article{ea281d5031b04f9aa96167e99b6fecfe,
title = "Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014",
abstract = "On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease (EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of {"}Imported{"} Viral Diseases{"}, ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made.",
keywords = "Diagnostics, Ebola virus, Laboratory preparedness, Viral haemorrhagic fever",
author = "Chantal Reusken and Matthias Niedrig and Suzan Pas and Pedro Anda and Sylvain Baize and Remi Charrel and {Di Caro}, Antonino and Christian Drosten and Fernandez-Garcia, {Maria Dolores} and Leticia Franco and Stephan Gunther and Isabelle Leparc-Goffart and Byron Martina and Delphine Pannetier and Anna Papa and Sanchez-Seco, {Maria Paz} and Olli Vapalahti and Marion Koopmans",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.jcv.2014.11.007",
language = "English",
volume = "62",
pages = "124--134",
journal = "Journal of Clinical Virology",
issn = "1386-6532",
publisher = "Elsevier",

}

TY - JOUR

T1 - Identification of essential outstanding questions for an adequate European laboratory response to Ebolavirus Zaire West Africa 2014

AU - Reusken, Chantal

AU - Niedrig, Matthias

AU - Pas, Suzan

AU - Anda, Pedro

AU - Baize, Sylvain

AU - Charrel, Remi

AU - Di Caro, Antonino

AU - Drosten, Christian

AU - Fernandez-Garcia, Maria Dolores

AU - Franco, Leticia

AU - Gunther, Stephan

AU - Leparc-Goffart, Isabelle

AU - Martina, Byron

AU - Pannetier, Delphine

AU - Papa, Anna

AU - Sanchez-Seco, Maria Paz

AU - Vapalahti, Olli

AU - Koopmans, Marion

PY - 2015/1/1

Y1 - 2015/1/1

N2 - On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease (EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made.

AB - On August 8 2014, the World Health Organization (WHO) declared the outbreak of Ebola Virus Disease (EVD) evolving in West Africa since December 2013, a Public Health Emergency of International Concern (PHEIC). It is expected that the outbreak of Ebolavirus Disease (EVD) in West Africa will lead to increased testing of individuals in Europe for EVD. The severity of the situation in West Africa warranted a critical appraisal of the laboratory preparedness and response for EVD, with a focus on information needs for laboratories involved in diagnostics of rare viral diseases associated with the European Network for the Diagnostics of "Imported" Viral Diseases", ENIVD. Essential knowledge and knowledge gaps for an adequate laboratory response focusing on virus properties, infection kinetics, tests specifics and field performances were identified. An inventory of the laboratory capacity for EVD diagnostics among ENIVD laboratories was made.

KW - Diagnostics

KW - Ebola virus

KW - Laboratory preparedness

KW - Viral haemorrhagic fever

UR - http://www.scopus.com/inward/record.url?scp=84920433934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920433934&partnerID=8YFLogxK

U2 - 10.1016/j.jcv.2014.11.007

DO - 10.1016/j.jcv.2014.11.007

M3 - Article

VL - 62

SP - 124

EP - 134

JO - Journal of Clinical Virology

JF - Journal of Clinical Virology

SN - 1386-6532

ER -